{"disease":{"id":"fragile-x-tremor-ataxia-syndrome","name":"fragile x tremor ataxia syndrome"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05233579","title":"Open-Label Trial of Sulforaphane in Premutation Carriers With FXTAS","phase":"NA","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"University of California, Davis","has_results":false},{"nct_id":"NCT04428567","title":"Treadmill Training in Fragile X-associated Tremor/Ataxia Syndrome","phase":"NA","overall_status":"TERMINATED","enrollment_count":3,"lead_sponsor_name":"Rush University Medical Center","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}